The landscape of dementia analysis has advanced substantially with the arrival of advanced biomarkers, which include amyloid PET scans, tau imaging, and blood-based exams which can detect Alzheimer's pathology many years ahead of indications emerge. Even though these technological innovations represent impressive development in being familiar with